Skip to content

Neurological signs in very high-risk infants and developmental outcome at school age

Neurological signs in very high-risk infants and developmental outcome at school age - Early neurological signs and outcome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50365
Enrollment
68
Registered
2017-09-18
Start date
2017-11-22
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral palsy

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: For the patients: participation in the LEARN2MOVE 0-2years project (L2M; n=43). Inclusion criteria for the original LEARN2MOVE 0-2 years project were age zero to nine months CA at enrolment and the presence of at least one of the following conditions: (1) cystic periventricular leukomalacia, (2) parenchymal lesion of the brain, (3) severe neonatal hypoxic-ischaemic encephalopathy with brain lesions on MRI, (4) neurological dysfunctions suggestive of the development of CP. For the control group: (1) typically developing (2) age 7-10 years (3) attending mainstream education

Exclusion criteria

Exclusion criteria: For the patients: Exclusion criteria of the LEARN2MOVE 0-2 years project were: - Children with severe congenital disorders - Caregivers having insufficient understanding of the Dutch language For the controls: - presence of a complicated neonatal history - presence of a neurodevelopmental disorder, such as cerebral palsy, developmental coordination disorder, autism spectrum disorder, learning disability, or attention deficit hyperactivity disorder - Presence of the complex form of minor neurological dysfunction (MND) - Caregivers having insufficient understanding of the Dutch language

Design outcomes

Primary

MeasureTime frame
Vineland-II For the study of the kneejerk with the control group: the latency to the phasic response to the kneen jerk

Secondary

MeasureTime frame
Neurological, motor, visual, cognitive and behavioural outcome

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)